237 related articles for article (PubMed ID: 23266179)
1. Small-molecule modulators of 14-3-3 protein-protein interactions.
Ottmann C
Bioorg Med Chem; 2013 Jul; 21(14):4058-62. PubMed ID: 23266179
[TBL] [Abstract][Full Text] [Related]
2. Small-Molecule Stabilization of the 14-3-3/Gab2 Protein-Protein Interaction (PPI) Interface.
Bier D; Bartel M; Sies K; Halbach S; Higuchi Y; Haranosono Y; Brummer T; Kato N; Ottmann C
ChemMedChem; 2016 Apr; 11(8):911-8. PubMed ID: 26644359
[TBL] [Abstract][Full Text] [Related]
3. Protein-protein interactions as drug targets.
Skwarczynska M; Ottmann C
Future Med Chem; 2015; 7(16):2195-219. PubMed ID: 26510391
[TBL] [Abstract][Full Text] [Related]
4. Molecular insight into specific 14-3-3 modulators: Inhibitors and stabilisers of protein-protein interactions of 14-3-3.
Hartman AM; Hirsch AKH
Eur J Med Chem; 2017 Aug; 136():573-584. PubMed ID: 28549334
[TBL] [Abstract][Full Text] [Related]
5. Stabilization and inhibition of protein-protein interactions: the 14-3-3 case study.
Milroy LG; Brunsveld L; Ottmann C
ACS Chem Biol; 2013 Jan; 8(1):27-35. PubMed ID: 23210482
[TBL] [Abstract][Full Text] [Related]
6. Small-molecule stabilization of protein-protein interactions: an underestimated concept in drug discovery?
Thiel P; Kaiser M; Ottmann C
Angew Chem Int Ed Engl; 2012 Feb; 51(9):2012-8. PubMed ID: 22308055
[TBL] [Abstract][Full Text] [Related]
7. Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update.
Cau Y; Valensin D; Mori M; Draghi S; Botta M
Curr Med Chem; 2018; 25(1):5-21. PubMed ID: 28462702
[TBL] [Abstract][Full Text] [Related]
8. Fragment-based Differential Targeting of PPI Stabilizer Interfaces.
Guillory X; Wolter M; Leysen S; Neves JF; Kuusk A; Genet S; Somsen B; Morrow JK; Rivers E; van Beek L; Patel J; Goodnow R; Schoenherr H; Fuller N; Cao Q; Doveston RG; Brunsveld L; Arkin MR; Castaldi P; Boyd H; Landrieu I; Chen H; Ottmann C
J Med Chem; 2020 Jul; 63(13):6694-6707. PubMed ID: 32501690
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 14-3-3 protein-protein interaction inhibitors that sensitize multidrug-resistant cancer cells to doxorubicin and the Akt inhibitor GSK690693.
Mori M; Vignaroli G; Cau Y; Dinić J; Hill R; Rossi M; Colecchia D; Pešić M; Link W; Chiariello M; Ottmann C; Botta M
ChemMedChem; 2014 May; 9(5):973-83. PubMed ID: 24715717
[TBL] [Abstract][Full Text] [Related]
10. A Structural Perspective on the Modulation of Protein-Protein Interactions with Small Molecules.
Demirel HC; Dogan T; Tuncbag N
Curr Top Med Chem; 2018; 18(8):700-713. PubMed ID: 29852872
[TBL] [Abstract][Full Text] [Related]
11. Hot spot-based design of small-molecule inhibitors for protein-protein interactions.
Guo W; Wisniewski JA; Ji H
Bioorg Med Chem Lett; 2014 Jun; 24(11):2546-54. PubMed ID: 24751445
[TBL] [Abstract][Full Text] [Related]
12. The first small-molecule inhibitor of 14-3-3s: modulating the master regulator.
Kaiser M; Ottmann C
Chembiochem; 2010 Oct; 11(15):2085-7. PubMed ID: 20839267
[No Abstract] [Full Text] [Related]
13. Computational techniques are valuable tools for the discovery of protein-protein interaction inhibitors: the 14-3-3σ case.
Corradi V; Mancini M; Santucci MA; Carlomagno T; Sanfelice D; Mori M; Vignaroli G; Falchi F; Manetti F; Radi M; Botta M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6867-71. PubMed ID: 21962576
[TBL] [Abstract][Full Text] [Related]
14. Virtual screening and experimental validation reveal novel small-molecule inhibitors of 14-3-3 protein-protein interactions.
Thiel P; Röglin L; Meissner N; Hennig S; Kohlbacher O; Ottmann C
Chem Commun (Camb); 2013 Oct; 49(76):8468-70. PubMed ID: 23939230
[TBL] [Abstract][Full Text] [Related]
15. Small molecules, peptides and natural products: getting a grip on 14-3-3 protein-protein modulation.
Bartel M; Schäfer A; Stevers LM; Ottmann C
Future Med Chem; 2014 May; 6(8):903-21. PubMed ID: 24962282
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule modulators for epigenetics targets.
Knapp S; Weinmann H
ChemMedChem; 2013 Nov; 8(11):1885-91. PubMed ID: 24127276
[TBL] [Abstract][Full Text] [Related]
17. Polypharmacological Perturbation of the 14-3-3 Adaptor Protein Interactome Stimulates Neurite Outgrowth.
Kaplan A; Andrei SA; van Regteren Altena A; Simas T; Banerjee SL; Kato N; Bisson N; Higuchi Y; Ottmann C; Fournier AE
Cell Chem Biol; 2020 Jun; 27(6):657-667.e6. PubMed ID: 32220335
[TBL] [Abstract][Full Text] [Related]
18. Identification of the first non-peptidic small molecule inhibitor of the c-Abl/14-3-3 protein-protein interactions able to drive sensitive and Imatinib-resistant leukemia cells to apoptosis.
Corradi V; Mancini M; Manetti F; Petta S; Santucci MA; Botta M
Bioorg Med Chem Lett; 2010 Oct; 20(20):6133-7. PubMed ID: 20832303
[TBL] [Abstract][Full Text] [Related]
19. Rational Design, Binding Studies, and Crystal-Structure Evaluation of the First Ligand Targeting the Dimerization Interface of the 14-3-3ζ Adapter Protein.
Ehlers M; Grad JN; Mittal S; Bier D; Mertel M; Ohl L; Bartel M; Briels J; Heimann M; Ottmann C; Sanchez-Garcia E; Hoffmann D; Schmuck C
Chembiochem; 2018 Mar; 19(6):591-595. PubMed ID: 29282826
[TBL] [Abstract][Full Text] [Related]
20. An optimised small-molecule stabiliser of the 14-3-3-PMA2 protein-protein interaction.
Richter A; Rose R; Hedberg C; Waldmann H; Ottmann C
Chemistry; 2012 May; 18(21):6520-7. PubMed ID: 22467351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
